250682-08-7

Basic information

• Product Name: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid
• Synonyms: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid
• CAS NO: 250682-08-7
• Molecular Formula: C₁₂H₁₂F₃NO₃
• Molecular Weight: 275.2237896
• Mol File: 250682-08-7.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(250682-08-7)
• EPA Substance Registry System: 3-Morpholin-4-yl-5-trifluoromethyl-benzoic acid(250682-08-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 250682-08-7(Hazardous Substances Data)

Upstream product

• 149793-69-1 3-fluoro-5-trifluoromethyl-benzonitrile 
• 250682-12-3 ethyl 3-fluoro-5-(trifluoromethyl)benzoate 
• 250682-07-6 3-morpholin-4-yl-5-trifluoromethyl-benzoic acid ethyl ester 
• 220954-14-3 3-(4-morpholinyl)-5-(trifluoromethyl)-benzonitrile 

Downstream Products

• 677704-47-1 N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-(4-morpholinyl)-5-(trifluoromethyl)-benzamide 
• 1095274-40-0 {5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetaic acid 
• 1095274-39-7 ethyl {5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetate 
• 1095273-34-9 1-[1-({5-[3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}acetyl)-4-piperidinyl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one 
• 250682-10-1 N-(4-methyl-3-nitro-phenyl)-3-morpholin-4-yl-5-trifluoromethyl-benzamide 
• 250682-06-5 N-(3-amino-4-methylphenyl)-3-morpholino-5-trifluoromethylbenzamide 
• 250682-09-8 3-Morpholino-5-trifluoromethylbenzoyl chloride 
• 1620069-14-8 (S)-N-(4-(1-(2-((2-hydroxypropyl)amino)pyrimidin-4-yl)-1H-imidazole-2-carbonyl)phenyl)-3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzamide 
• 1620069-07-9 (S)-N-(3-(1-(2-((2-hydroxypropyl)amino)pyrimidin-4-yl)-1H-imidazole-2-carbonyl)phenyl)-3-morpholino-5-(trifluoromethyl)benzamide 
• 1620069-00-2 (S)-N-(3-((1-(2-((2-hydroxypropyl)amino)pyrimidin-4-yl)-1H-imidazol-2-yl)methyl)phenyl)-3-morpholino-5-(trifluoromethyl)benzamide 
• 1374585-39-3 C₃₂H₂₆F₃N₅O₃ 
• 1346440-98-9 N-(3-(1-benzyl-7-oxo-1,6,7,8-tetrahydropyrazolo[3,4-b]-[1,4]diazepin-5-yl)phenyl)-3-morpholino-5-(trifluoromethyl)-benzamide 
• 1370335-35-5 3-morpholino 
• 1314863-37-0 N-[4-(4-benzamido-1H-pyrrolo[3,2-c]pyridin-1-yl)phenyl]-3-morpholino-5-(trifluoromethyl)benzamide 

Relevant articles and documents

Novel imidazole derivatives

The invention is concerned with novel imidazole derivatives of formula (I), wherein m, E, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and in the claims, as we

5-PHENYL-1,3,4-OXADIAZOL-2-YL-ACETYL-4-PIPERIDINYL DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The present invention relates to novel compounds that are CGRP receptor antagonists, processes for their preparation, to compositions containing them and to their use in the treatment of migraine, headache, and cluster headache.

HETEROCYCLIC CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory, anti-pain or anti-cancer agents. There are further provided m